HEALTH AND WELLNESS
Exploring Ampligen's Role in Pancreatic Cancer - AIM
AIM ImmunoTech's strategy for pancreatic cancer highlights Ampligen's potential as a maintenance therapy post-chemotherapy.
UNITED STATESEUROPEAN UNIONFOLFIRINOXAIM IMMUNO TECH INCAIM CHIEF EXECUTIVE OFFICER THOMAS K EQUELS